Purpose: The relationship between tacrolimus intrapatient variability (IPV) and its metabolism-associated single-nucleotide polymorphisms (SNPs) in liver transplantation (LT) remains unclear. Moreover, the influence of donor SNP on recipient IPV is poorly understood. Our objective was to investigate how SNPs affect tacrolimus IPV by analyzing both donor and recipient SNP data in LT.
Methods: This retrospective study examined the association between tacrolimus IPV and eight specific SNPs in 50 adult LT recipients and 50 LT donors genotyped for CYP3A5, ABCB1, ABCC2, and POR genes and their SNPs. Recipients were divided into high IPV (≥30) and low IPV (<30) groups based on 3-12 months after LT IPV calculations. Multivariate logistic regression was used to identify risk factors for high IPV. Post-LT long-term outcomes were also compared between the groups.
Results: Two SNPs were significantly associated with high IPV in multivariate analysis. Recipient ABCB1 1236C>T genotypes CT and CC (odds ratio [OR], 13.969; 95% confidence interval [CI], 1.738-112.300; P = 0.013), donors' CYP3A5 6986A>G genotypes GA and GG (OR, 4.390; 95% CI, 1.005-19.178; P = 0.049), and glucose ≥120 mg/dL at 3 months (OR, 6.494; 95% CI, 1.300-32.168; P = 0.024) were associated with high IPV. However, post-LT long-term outcomes were similar between the groups.
Conclusion: SNPs of donor CYP3A5 and recipient ABCB1 can significantly influence tacrolimus IPV in patients undergoing living donor LT. Identifying these SNPs can help determine high IPV-prone patients, facilitate close monitoring of high IPV-susceptible groups, and improve outcomes.
目的:肝移植(LT)中他克莫司患者内变异性(IPV)与其代谢相关单核苷酸多态性(snp)之间的关系尚不清楚。此外,供体SNP对受体IPV的影响尚不清楚。我们的目的是通过分析LT供体和受体SNP数据来研究SNP是如何影响他克莫司IPV的。方法:本回顾性研究检测了50名成年LT受体和50名LT供体CYP3A5、ABCB1、ABCC2和POR基因分型的8个特异性SNP与他克莫司IPV之间的关系。将受者分为高IPV组(≥30)和低IPV组(结果:多因素分析显示,两个snp与高IPV显著相关。受体ABCB1 1236C>T基因型CT和CC(优势比[OR], 13.969; 95%可信区间[CI], 1.738 ~ 112.300; P = 0.013)、供体CYP3A5 6986A>G基因型GA和GG(优势比,4.390;95% CI, 1.005 ~ 19.178; P = 0.049)、3个月时血糖≥120 mg/dL(优势比,6.494;95% CI, 1.300 ~ 32.168; P = 0.024)与高IPV相关。然而,两组间术后的长期结果相似。结论:供体CYP3A5和受体ABCB1 snp可显著影响活体供体lt患者他克莫司IPV,识别这些snp有助于确定ipvv高易发患者,便于密切监测ipvv高易感人群,改善预后。
{"title":"Single-nucleotide polymorphisms of donor <i>CYP3A5</i> and recipient <i>ABCB1</i> affect tacrolimus intrapatient variability in living donor liver transplantation: a retrospective cohort study.","authors":"Saran Ochir Gongor, Kwang-Woong Lee, Eun-Woo Choi, Jae-Yoon Kim, Jeong-Moo Lee, Suk Kyun Hong, YoungRok Choi, Nam-Joon Yi, Kyung-Suk Suh","doi":"10.4174/astr.2025.109.4.252","DOIUrl":"10.4174/astr.2025.109.4.252","url":null,"abstract":"<p><strong>Purpose: </strong>The relationship between tacrolimus intrapatient variability (IPV) and its metabolism-associated single-nucleotide polymorphisms (SNPs) in liver transplantation (LT) remains unclear. Moreover, the influence of donor SNP on recipient IPV is poorly understood. Our objective was to investigate how SNPs affect tacrolimus IPV by analyzing both donor and recipient SNP data in LT.</p><p><strong>Methods: </strong>This retrospective study examined the association between tacrolimus IPV and eight specific SNPs in 50 adult LT recipients and 50 LT donors genotyped for <i>CYP3A5</i>, <i>ABCB1</i>, <i>ABCC2</i>, and <i>POR</i> genes and their SNPs. Recipients were divided into high IPV (≥30) and low IPV (<30) groups based on 3-12 months after LT IPV calculations. Multivariate logistic regression was used to identify risk factors for high IPV. Post-LT long-term outcomes were also compared between the groups.</p><p><strong>Results: </strong>Two SNPs were significantly associated with high IPV in multivariate analysis. Recipient <i>ABCB1</i> 1236C>T genotypes CT and CC (odds ratio [OR], 13.969; 95% confidence interval [CI], 1.738-112.300; P = 0.013), donors' <i>CYP3A5</i> 6986A>G genotypes GA and GG (OR, 4.390; 95% CI, 1.005-19.178; P = 0.049), and glucose ≥120 mg/dL at 3 months (OR, 6.494; 95% CI, 1.300-32.168; P = 0.024) were associated with high IPV. However, post-LT long-term outcomes were similar between the groups.</p><p><strong>Conclusion: </strong>SNPs of donor <i>CYP3A5</i> and recipient <i>ABCB1</i> can significantly influence tacrolimus IPV in patients undergoing living donor LT. Identifying these SNPs can help determine high IPV-prone patients, facilitate close monitoring of high IPV-susceptible groups, and improve outcomes.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 4","pages":"252-260"},"PeriodicalIF":1.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145328199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.4174/astr.2025.109.4.224
Tao Wang, Jun Liu
Purpose: In intrahepatic cholangiocarcinoma (ICC), the interactions among CA19-9, CA125, and CEA are not yet fully understood. This study aims to investigate the relationship between a combined grading system of CA19-9, CA125, and CEA (3C grade) and the prognosis of ICC patients, as well as its predictive capability for prognosis.
Methods: The patients were categorized into different 3C grades based on preoperative serum levels of CA19-9, CA125, and CEA to explore the relationship between 3C grade and overall survival (OS) and recurrence-free survival (RFS), assessing the predictive value of 3C grade for OS and RFS.
Results: A total of 535 eligible patients were included and were classified into different 3C grade groups. Significant differences were observed among different 3C grade groups in clinical characteristics such as tumor size (P = 0.006) and lymph node metastasis (P = 0.006). The Kaplan-Meier curves demonstrated significant differences in OS and RFS among the different 3C grade groups (P < 0.001). The receiver operating characteristic curve analysis revealed that the 3C grade had superior predictive value for OS and RFS compared to individual tumor markers (P < 0.05 for each).
Conclusion: This study revealed that the 3C grade was identified as an independent prognostic factor for OS and RFS after radical surgery of ICC, demonstrating superior predictive value for OS and RFS compared to single tumor markers. The 3C grade model holds promise to assist clinicians in preoperative assessment of ICC patients undergoing radical surgery, thereby aiding in the development of personalized treatment strategies.
{"title":"Combined CA19-9, CA125, and CEA to predict prognosis of patients with intrahepatic cholangiocarcinoma after radical surgery: a retrospective, multi-institutional study.","authors":"Tao Wang, Jun Liu","doi":"10.4174/astr.2025.109.4.224","DOIUrl":"10.4174/astr.2025.109.4.224","url":null,"abstract":"<p><strong>Purpose: </strong>In intrahepatic cholangiocarcinoma (ICC), the interactions among CA19-9, CA125, and CEA are not yet fully understood. This study aims to investigate the relationship between a combined grading system of CA19-9, CA125, and CEA (3C grade) and the prognosis of ICC patients, as well as its predictive capability for prognosis.</p><p><strong>Methods: </strong>The patients were categorized into different 3C grades based on preoperative serum levels of CA19-9, CA125, and CEA to explore the relationship between 3C grade and overall survival (OS) and recurrence-free survival (RFS), assessing the predictive value of 3C grade for OS and RFS.</p><p><strong>Results: </strong>A total of 535 eligible patients were included and were classified into different 3C grade groups. Significant differences were observed among different 3C grade groups in clinical characteristics such as tumor size (P = 0.006) and lymph node metastasis (P = 0.006). The Kaplan-Meier curves demonstrated significant differences in OS and RFS among the different 3C grade groups (P < 0.001). The receiver operating characteristic curve analysis revealed that the 3C grade had superior predictive value for OS and RFS compared to individual tumor markers (P < 0.05 for each).</p><p><strong>Conclusion: </strong>This study revealed that the 3C grade was identified as an independent prognostic factor for OS and RFS after radical surgery of ICC, demonstrating superior predictive value for OS and RFS compared to single tumor markers. The 3C grade model holds promise to assist clinicians in preoperative assessment of ICC patients undergoing radical surgery, thereby aiding in the development of personalized treatment strategies.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 4","pages":"224-234"},"PeriodicalIF":1.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145328215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-08DOI: 10.4174/astr.2025.109.3.207
Ji Hyeong Song, Inyoung Na, Song-Yi Kim, Youn Ju Lee, Sun Jong Han, Sang Il Youn, Sa-Hong Min, Jin Soo Kim
Purpose: Laparoscopic appendectomy, a routine surgical procedure for acute appendicitis, is commonly performed in general hospitals. However, postoperative outcomes based on surgical subspecialty have not been well established. This study aimed to compare surgical outcomes of laparoscopic appendectomy across different surgical subspecialties using risk-adjusted cumulative summation (RA-CUSUM) analysis.
Methods: A retrospective analysis was conducted on 631 patients undergoing laparoscopic appendectomy between July 2020 and December 2022. Surgeons were categorized into gastrointestinal (GI) or non-GI groups and senior or young groups. Surgical failure was defined as operation time exceeding the mean plus 2 standard deviations, presence of postoperative complications, or readmission within 30 days after surgery. RA-CUSUM analysis was employed to evaluate surgical failure within each group.
Results: The GI group performed more partial cecectomies (P = 0.017) and had longer operation times (P = 0.019) than the non-GI group. The senior group exhibited shorter operation time (P < 0.001), reduced length of stay (P = 0.011), and a higher complication rate (P < 0.001) than the young group. RA-CUSUM analysis indicated a decrease in surgical failure as accumulation progressed in both senior and young groups, as well as in the GI and non-GI groups.
Conclusion: Outcomes of laparoscopic appendectomy varied by subspecialty and length of experience. However, each surgeon showed trends of decreasing surgical failure over time. These results suggest that the surgeon's subspecialty minimally affects the outcomes of laparoscopic appendectomy, reflecting its fundamental nature within general surgery.
{"title":"Comparative analysis of surgical outcomes of laparoscopic appendectomy performed by six surgeons with different subspecialties: a retrospective cohort study using risk-adjusted cumulative summation.","authors":"Ji Hyeong Song, Inyoung Na, Song-Yi Kim, Youn Ju Lee, Sun Jong Han, Sang Il Youn, Sa-Hong Min, Jin Soo Kim","doi":"10.4174/astr.2025.109.3.207","DOIUrl":"10.4174/astr.2025.109.3.207","url":null,"abstract":"<p><strong>Purpose: </strong>Laparoscopic appendectomy, a routine surgical procedure for acute appendicitis, is commonly performed in general hospitals. However, postoperative outcomes based on surgical subspecialty have not been well established. This study aimed to compare surgical outcomes of laparoscopic appendectomy across different surgical subspecialties using risk-adjusted cumulative summation (RA-CUSUM) analysis.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 631 patients undergoing laparoscopic appendectomy between July 2020 and December 2022. Surgeons were categorized into gastrointestinal (GI) or non-GI groups and senior or young groups. Surgical failure was defined as operation time exceeding the mean plus 2 standard deviations, presence of postoperative complications, or readmission within 30 days after surgery. RA-CUSUM analysis was employed to evaluate surgical failure within each group.</p><p><strong>Results: </strong>The GI group performed more partial cecectomies (P = 0.017) and had longer operation times (P = 0.019) than the non-GI group. The senior group exhibited shorter operation time (P < 0.001), reduced length of stay (P = 0.011), and a higher complication rate (P < 0.001) than the young group. RA-CUSUM analysis indicated a decrease in surgical failure as accumulation progressed in both senior and young groups, as well as in the GI and non-GI groups.</p><p><strong>Conclusion: </strong>Outcomes of laparoscopic appendectomy varied by subspecialty and length of experience. However, each surgeon showed trends of decreasing surgical failure over time. These results suggest that the surgeon's subspecialty minimally affects the outcomes of laparoscopic appendectomy, reflecting its fundamental nature within general surgery.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"207-214"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457793/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-08DOI: 10.4174/astr.2025.109.3.194
Byeong-Gon Na, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sang Hoon Kim, Sung-Gyu Lee
Purpose: Huge (≥10 cm) hepatocellular carcinoma (HCC) poses significant treatment and prognosis challenges. This study aimed to determine whether preoperative transarterial chemoembolization (TACE) for huge HCC is necessary.
Methods: This single-center, retrospective cohort study evaluated 435 patients with huge HCC who underwent upfront hepatectomy or hepatectomy after preoperative TACE from January 2009 to December 2018. TACE's impact on survival and prognostic factors, including microvascular invasion (MVI) and satellite nodules (SNs), was analyzed.
Results: The preoperative TACE group (n = 33) had a lower incidence of MVI (P = 0.009) and higher postoperative morbidity (P = 0.001), particularly pleural effusion (P = 0.004) and Clavien-Dindo class III-IV complications (P = 0.033), compared with the upfront hepatectomy group (n = 402). Short-term mortality (P = 0.828) and recurrence within 6 months (P = 0.654) were comparable between groups. The 1-, 3-, and 5-year survival curves showed no significant between-group differences in recurrence-free survival (RFS) (P = 0.172) and overall survival (OS) (P = 0.450). Local regional therapy for intrahepatic recurrences and surgical resection for extrahepatic recurrences were associated with better OS. MVI, SN, and hepatic vein tumor thrombosis were identified as significant risk factors for poorer RFS and OS. In patients without SN, preoperative TACE improved RFS (P = 0.039) but not OS.
Conclusion: Preoperative TACE for huge HCC was associated with reduced MVI but did not improve RFS and OS. Survival outcomes were more significantly influenced by SN, suggesting that upfront hepatectomy without TACE should be prioritized.
{"title":"Limited survival benefit of preoperative transarterial chemoembolization in huge hepatocellular carcinoma due to the prognostic impact of satellite nodules: a retrospective cohort study.","authors":"Byeong-Gon Na, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sang Hoon Kim, Sung-Gyu Lee","doi":"10.4174/astr.2025.109.3.194","DOIUrl":"10.4174/astr.2025.109.3.194","url":null,"abstract":"<p><strong>Purpose: </strong>Huge (≥10 cm) hepatocellular carcinoma (HCC) poses significant treatment and prognosis challenges. This study aimed to determine whether preoperative transarterial chemoembolization (TACE) for huge HCC is necessary.</p><p><strong>Methods: </strong>This single-center, retrospective cohort study evaluated 435 patients with huge HCC who underwent upfront hepatectomy or hepatectomy after preoperative TACE from January 2009 to December 2018. TACE's impact on survival and prognostic factors, including microvascular invasion (MVI) and satellite nodules (SNs), was analyzed.</p><p><strong>Results: </strong>The preoperative TACE group (n = 33) had a lower incidence of MVI (P = 0.009) and higher postoperative morbidity (P = 0.001), particularly pleural effusion (P = 0.004) and Clavien-Dindo class III-IV complications (P = 0.033), compared with the upfront hepatectomy group (n = 402). Short-term mortality (P = 0.828) and recurrence within 6 months (P = 0.654) were comparable between groups. The 1-, 3-, and 5-year survival curves showed no significant between-group differences in recurrence-free survival (RFS) (P = 0.172) and overall survival (OS) (P = 0.450). Local regional therapy for intrahepatic recurrences and surgical resection for extrahepatic recurrences were associated with better OS. MVI, SN, and hepatic vein tumor thrombosis were identified as significant risk factors for poorer RFS and OS. In patients without SN, preoperative TACE improved RFS (P = 0.039) but not OS.</p><p><strong>Conclusion: </strong>Preoperative TACE for huge HCC was associated with reduced MVI but did not improve RFS and OS. Survival outcomes were more significantly influenced by SN, suggesting that upfront hepatectomy without TACE should be prioritized.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"194-206"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-08DOI: 10.4174/astr.2025.109.3.144
Huiyin Zhu, Lifen Bai, Ming Zhou, Ling Zhou
Purpose: This study was designed to investigate the efficacy and safety of radiofrequency ablation (RFA) for treating thyroid nodules (TNs).
Methods: We retrospectively included the patients who underwent RFA for TNs in our hospital between January 2020 and December 2023. Preoperative and postoperative data including age, sex, body mass index, and thyroid hormone levels were collected from each patient. The efficacy of RFA on TNs was analyzed by evaluating the volume reduction (VR) and volume reduction rate (VRR) at postoperative months 1, 3, 6, and 12, respectively. In addition, the efficacy of RFA on nodule composition and postoperative complications was evaluated. Finally, a subgroup analysis was conducted to evaluate the potential risks.
Results: VR at postoperative month 12 was significantly higher than those at postoperative months 1, 3, and 6, respectively (all P < 0.001). VRR at month 12 was significantly higher than that of months 1, 3, and 6, respectively (all P < 0.001).
Conclusion: RFA is an effective option for treating TNs with good safety. VR and VRR showed significant increase after RFA compared with the pretreatment levels.
{"title":"Radiofrequency ablation for symptomatic, non-functioning thyroid nodules: a single-center retrospective observational study.","authors":"Huiyin Zhu, Lifen Bai, Ming Zhou, Ling Zhou","doi":"10.4174/astr.2025.109.3.144","DOIUrl":"10.4174/astr.2025.109.3.144","url":null,"abstract":"<p><strong>Purpose: </strong>This study was designed to investigate the efficacy and safety of radiofrequency ablation (RFA) for treating thyroid nodules (TNs).</p><p><strong>Methods: </strong>We retrospectively included the patients who underwent RFA for TNs in our hospital between January 2020 and December 2023. Preoperative and postoperative data including age, sex, body mass index, and thyroid hormone levels were collected from each patient. The efficacy of RFA on TNs was analyzed by evaluating the volume reduction (VR) and volume reduction rate (VRR) at postoperative months 1, 3, 6, and 12, respectively. In addition, the efficacy of RFA on nodule composition and postoperative complications was evaluated. Finally, a subgroup analysis was conducted to evaluate the potential risks.</p><p><strong>Results: </strong>VR at postoperative month 12 was significantly higher than those at postoperative months 1, 3, and 6, respectively (all P < 0.001). VRR at month 12 was significantly higher than that of months 1, 3, and 6, respectively (all P < 0.001).</p><p><strong>Conclusion: </strong>RFA is an effective option for treating TNs with good safety. VR and VRR showed significant increase after RFA compared with the pretreatment levels.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"144-150"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-08DOI: 10.4174/astr.2025.109.3.121
Jai Young Cho
{"title":"Surgeon's aspect of an expert consensus-based practical recommendation for surgical treatment of hepatocellular carcinoma.","authors":"Jai Young Cho","doi":"10.4174/astr.2025.109.3.121","DOIUrl":"10.4174/astr.2025.109.3.121","url":null,"abstract":"","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"121-122"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-08DOI: 10.4174/astr.2025.109.3.169
Won Woong Kim, Daham Kim, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung
Purpose: Glycolytic enzymes have been extensively studied in various cancer types, revealing their aggressive characteristics and roles in tumor progression. This study aimed to determine whether the expression of glycolytic enzymes is associated with aggressiveness in the presence or absence of chronic lymphocytic thyroiditis (CLT).
Methods: The expression of hexokinase 2, lactate dehydrogenase A (LDHA), pyruvate kinase isoform M2 (PKM2), glucose transporter 1 (GLUT1), and monocarboxylate transporter 4 (MCT4) was examined in 233 papillary thyroid carcinoma (PTC) specimens by immunohistochemistry. We evaluated whether the expression of these glycolytic enzymes correlates with lymph node metastasis, extrathyroidal extension (ETE), and recurrence rate, both with and without CLT. In addition, we analyzed the correlation between glycolytic enzyme messenger RNA expression and risk factors in PTC using The Cancer Genome Atlas.
Results: All glycolytic enzymes and transporter proteins were overexpressed in PTC compared with normal tissue. PKM2 expression was most highly correlated with the other glycolytic enzymes. High PKM2 expression was significantly linked to increased recurrence risk in patients without CLT (hazard ratio, 1.76; 95% confidence interval, 1.01-3.06; P = 0.046), but this association was not observed in those with CLT.
Conclusion: Overexpression of LDHA, PKM2, GLUT1, and MCT4 is associated with PTC. CLT is significantly associated with an increased incidence of gross ETE and, paradoxically, with a reduced recurrence rate in PTC. LDHA expression was lower in the presence of CLT, whereas PKM2 remained consistently linked to a higher recurrence rate in its absence. Among the evaluated glycolytic enzymes, PKM2 may serve as a biomarker for recurrence in PTC.
目的:糖酵解酶在各种类型的肿瘤中被广泛研究,揭示其侵袭性特征及其在肿瘤进展中的作用。本研究旨在确定糖酵解酶的表达是否与慢性淋巴细胞性甲状腺炎(CLT)存在或不存在时的侵袭性有关。方法:采用免疫组化方法检测233例甲状腺乳头状癌(PTC)标本中己糖激酶2、乳酸脱氢酶A (LDHA)、丙酮酸激酶异构体M2 (PKM2)、葡萄糖转运蛋白1 (GLUT1)、单羧酸转运蛋白4 (MCT4)的表达。我们评估了这些糖酵解酶的表达是否与淋巴结转移、甲状腺外展(ETE)和复发率相关,无论是否有CLT。此外,我们利用the Cancer Genome Atlas分析了PTC中糖酵解酶信使RNA表达与危险因素的相关性。结果:与正常组织相比,PTC中所有糖酵解酶和转运蛋白均过表达。PKM2的表达与其他糖酵解酶的表达高度相关。PKM2高表达与无CLT患者复发风险增加显著相关(风险比为1.76;95%可信区间为1.01-3.06;P = 0.046),但在有CLT的患者中未观察到这种关联。结论:LDHA、PKM2、GLUT1、MCT4过表达与PTC相关。CLT与总ETE发生率的增加显著相关,而与PTC复发率的降低矛盾。CLT存在时LDHA表达较低,而PKM2在没有CLT的情况下仍然与较高的复发率有关。在评估的糖酵解酶中,PKM2可能作为PTC复发的生物标志物。
{"title":"The effect of glycolytic enzyme expression and thyroiditis on the aggressiveness of papillary thyroid carcinoma: a retrospective cohort study.","authors":"Won Woong Kim, Daham Kim, Jin Kyong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung","doi":"10.4174/astr.2025.109.3.169","DOIUrl":"10.4174/astr.2025.109.3.169","url":null,"abstract":"<p><strong>Purpose: </strong>Glycolytic enzymes have been extensively studied in various cancer types, revealing their aggressive characteristics and roles in tumor progression. This study aimed to determine whether the expression of glycolytic enzymes is associated with aggressiveness in the presence or absence of chronic lymphocytic thyroiditis (CLT).</p><p><strong>Methods: </strong>The expression of hexokinase 2, lactate dehydrogenase A (LDHA), pyruvate kinase isoform M2 (PKM2), glucose transporter 1 (GLUT1), and monocarboxylate transporter 4 (MCT4) was examined in 233 papillary thyroid carcinoma (PTC) specimens by immunohistochemistry. We evaluated whether the expression of these glycolytic enzymes correlates with lymph node metastasis, extrathyroidal extension (ETE), and recurrence rate, both with and without CLT. In addition, we analyzed the correlation between glycolytic enzyme messenger RNA expression and risk factors in PTC using The Cancer Genome Atlas.</p><p><strong>Results: </strong>All glycolytic enzymes and transporter proteins were overexpressed in PTC compared with normal tissue. PKM2 expression was most highly correlated with the other glycolytic enzymes. High PKM2 expression was significantly linked to increased recurrence risk in patients without CLT (hazard ratio, 1.76; 95% confidence interval, 1.01-3.06; P = 0.046), but this association was not observed in those with CLT.</p><p><strong>Conclusion: </strong>Overexpression of LDHA, PKM2, GLUT1, and MCT4 is associated with PTC. CLT is significantly associated with an increased incidence of gross ETE and, paradoxically, with a reduced recurrence rate in PTC. LDHA expression was lower in the presence of CLT, whereas PKM2 remained consistently linked to a higher recurrence rate in its absence. Among the evaluated glycolytic enzymes, PKM2 may serve as a biomarker for recurrence in PTC.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"169-184"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-08DOI: 10.4174/astr.2025.109.3.185
Min Hong Lee, Yoon Mo Kim, Mi Kyung Oh, Hyun Il Kim, Min Gyu Kim
Purpose: Gastric perforation remains a life-threatening condition despite advances in medical therapies and surgical techniques. In clinical emergencies involving gastric perforation, distinguishing between benign and malignant etiologies remains uncertain until histological confirmation is obtained.
Methods: This study analyzed 79 patients who underwent emergency gastrectomy for gastric perforation between 2010 and 2024. Patients were categorized into ulcer and cancer groups based on pathological findings. Clinical data, including preoperative conditions and postoperative outcomes, were analyzed using univariate and multivariate analyses.
Results: Elderly (aged ≥75 years), symptom duration ≥48 hours, and American Society of Anesthesiologists physical status classification IV-E were significant risk factors for postoperative mortality. The cancer group had longer operation times, while ventilator use was more common in the ulcer group. No significant differences were observed in overall mortality rates.
Conclusion: Emergency gastrectomy can be a viable treatment for gastric perforation in regions with a high incidence of gastric cancer. However, patients with advanced age, delayed symptom onset, or poor physical status require careful surgical planning. Tailored strategies may improve outcomes, particularly in high-incidence regions for gastric cancer.
{"title":"Risk factor analysis and surgical outcomes in emergency gastrectomy for gastric perforation: a single-center retrospective cohort study.","authors":"Min Hong Lee, Yoon Mo Kim, Mi Kyung Oh, Hyun Il Kim, Min Gyu Kim","doi":"10.4174/astr.2025.109.3.185","DOIUrl":"10.4174/astr.2025.109.3.185","url":null,"abstract":"<p><strong>Purpose: </strong>Gastric perforation remains a life-threatening condition despite advances in medical therapies and surgical techniques. In clinical emergencies involving gastric perforation, distinguishing between benign and malignant etiologies remains uncertain until histological confirmation is obtained.</p><p><strong>Methods: </strong>This study analyzed 79 patients who underwent emergency gastrectomy for gastric perforation between 2010 and 2024. Patients were categorized into ulcer and cancer groups based on pathological findings. Clinical data, including preoperative conditions and postoperative outcomes, were analyzed using univariate and multivariate analyses.</p><p><strong>Results: </strong>Elderly (aged ≥75 years), symptom duration ≥48 hours, and American Society of Anesthesiologists physical status classification IV-E were significant risk factors for postoperative mortality. The cancer group had longer operation times, while ventilator use was more common in the ulcer group. No significant differences were observed in overall mortality rates.</p><p><strong>Conclusion: </strong>Emergency gastrectomy can be a viable treatment for gastric perforation in regions with a high incidence of gastric cancer. However, patients with advanced age, delayed symptom onset, or poor physical status require careful surgical planning. Tailored strategies may improve outcomes, particularly in high-incidence regions for gastric cancer.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"185-193"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-08DOI: 10.4174/astr.2025.109.3.162
Yong Hyun Jang, Ru Ri Lee, Yongkeun Park
Purpose: Although neoadjuvant therapy (NAT) has been applied in patients with borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC), limited data on long-term outcomes are available to support its role as a potentially curable therapeutic option. This study assessed the probability of being statistically cured among these patients.
Methods: The literature search was conducted focusing on previous studies that investigated the long-term recurrence-free survival rates of patients with BR-PDAC after NAT followed by radical resection. The reference cohort data were extracted from studies including patients undergoing upfront radical resection for resectable PDAC. Pseudo-individual patient data were reconstructed from the original papers. A non-mixture cure model was adopted to estimate the statistical cure fraction.
Results: Twelve retrospective studies reporting long-term recurrence-free survival after NAT followed by radical resection for patients with BR-PDAC were secondarily analyzed. The probability of being statistically cured in these patients was 8.1% (95% confidence interval [CI], 5.4%-11.5%), which was lower than that of the reference cohort of 5 retrospective studies (14.7%; 95% CI, 13.2%-16.4%). There was a statistically significant difference between the 2 groups (hazard ratio, 1.110; 95% CI, 1.007-1.224).
Conclusion: From this study, we concluded that a cure can be expected in around eight percent of patients with BR-PDAC after NAT followed by radical resection, which would be helpful in counseling patients, as well as deciding whether to perform the surgery.
{"title":"Statistical cure fraction in patients with borderline resectable pancreatic ductal adenocarcinoma undergoing neoadjuvant therapy followed by radical resection: a secondary analysis of reconstructed individual patient data.","authors":"Yong Hyun Jang, Ru Ri Lee, Yongkeun Park","doi":"10.4174/astr.2025.109.3.162","DOIUrl":"10.4174/astr.2025.109.3.162","url":null,"abstract":"<p><strong>Purpose: </strong>Although neoadjuvant therapy (NAT) has been applied in patients with borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC), limited data on long-term outcomes are available to support its role as a potentially curable therapeutic option. This study assessed the probability of being statistically cured among these patients.</p><p><strong>Methods: </strong>The literature search was conducted focusing on previous studies that investigated the long-term recurrence-free survival rates of patients with BR-PDAC after NAT followed by radical resection. The reference cohort data were extracted from studies including patients undergoing upfront radical resection for resectable PDAC. Pseudo-individual patient data were reconstructed from the original papers. A non-mixture cure model was adopted to estimate the statistical cure fraction.</p><p><strong>Results: </strong>Twelve retrospective studies reporting long-term recurrence-free survival after NAT followed by radical resection for patients with BR-PDAC were secondarily analyzed. The probability of being statistically cured in these patients was 8.1% (95% confidence interval [CI], 5.4%-11.5%), which was lower than that of the reference cohort of 5 retrospective studies (14.7%; 95% CI, 13.2%-16.4%). There was a statistically significant difference between the 2 groups (hazard ratio, 1.110; 95% CI, 1.007-1.224).</p><p><strong>Conclusion: </strong>From this study, we concluded that a cure can be expected in around eight percent of patients with BR-PDAC after NAT followed by radical resection, which would be helpful in counseling patients, as well as deciding whether to perform the surgery.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"162-168"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01Epub Date: 2025-09-08DOI: 10.4174/astr.2025.109.3.151
Hilal Hwang, Sun Min Lee, Shin-Young Park, Jin Wook Yi, Yun-Mee Choe, Sun Keun Choi
Purpose: Although Korea's medical care uses advanced technology, there are not enough doctors working in rural areas, and fewer doctors are working in challenging fields such as surgery. Medical care in Türkiye is very cost-effective for patients, but doctors have too many patients and too much work. This study compared the healthcare systems of the 2 countries and the gaps felt by surgeons.
Methods: A comparative analysis was conducted using a comprehensive literature review and a questionnaire involving medical professionals from various working positions in both countries.
Results: Doctors in both countries felt that there was a large medical gap between regions and reported that the number of doctors was small. Turkish doctors experience excessive patient overload, contributing to high stress and feelings of overwork. They also showed lower job satisfaction than in Korea. The common reasons for the low preference for general surgery residencies include intense training, excessive workload, and high risk in both countries.
Conclusion: This study identified the key challenges in medical and surgical training in Korea and Türkiye. In Korea, shortages can be addressed by reforms in general surgery residency, the development of a balanced residency selection system, and the provision of work opportunities for non-Korean professionals. In Türkiye, improving remuneration and alleviating unsafe work environments is urgent. Both countries should incentivize rural services to ensure balanced doctor distribution. Collaborative initiatives informed by these findings can enhance medical education and healthcare delivery in both countries.
{"title":"Comparative analysis of surgical residency environments between Korea and Türkiye: a cross-sectional study.","authors":"Hilal Hwang, Sun Min Lee, Shin-Young Park, Jin Wook Yi, Yun-Mee Choe, Sun Keun Choi","doi":"10.4174/astr.2025.109.3.151","DOIUrl":"10.4174/astr.2025.109.3.151","url":null,"abstract":"<p><strong>Purpose: </strong>Although Korea's medical care uses advanced technology, there are not enough doctors working in rural areas, and fewer doctors are working in challenging fields such as surgery. Medical care in Türkiye is very cost-effective for patients, but doctors have too many patients and too much work. This study compared the healthcare systems of the 2 countries and the gaps felt by surgeons.</p><p><strong>Methods: </strong>A comparative analysis was conducted using a comprehensive literature review and a questionnaire involving medical professionals from various working positions in both countries.</p><p><strong>Results: </strong>Doctors in both countries felt that there was a large medical gap between regions and reported that the number of doctors was small. Turkish doctors experience excessive patient overload, contributing to high stress and feelings of overwork. They also showed lower job satisfaction than in Korea. The common reasons for the low preference for general surgery residencies include intense training, excessive workload, and high risk in both countries.</p><p><strong>Conclusion: </strong>This study identified the key challenges in medical and surgical training in Korea and Türkiye. In Korea, shortages can be addressed by reforms in general surgery residency, the development of a balanced residency selection system, and the provision of work opportunities for non-Korean professionals. In Türkiye, improving remuneration and alleviating unsafe work environments is urgent. Both countries should incentivize rural services to ensure balanced doctor distribution. Collaborative initiatives informed by these findings can enhance medical education and healthcare delivery in both countries.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"109 3","pages":"151-161"},"PeriodicalIF":1.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}